Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Flavonil 600 is a dietary supplement formulated as a double-layer tablet, designed to support microcirculation and promote the normal function of blood vessels. It contains 300 mg of rutin, a bioflavonoid known for its antioxidant and vasoprotective properties, and 300 mg of bromelain, a proteolytic enzyme derived from pineapple with draining and anti-inflammatory actions. The formulation is further enhanced with vitamin C (L-ascorbic acid), which contributes to normal collagen formation essential for healthy blood vessel function. It is primarily indicated for conditions such as leg swelling, venous insufficiency, and capillary fragility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Flavonil 600.